On Nov. 17, 2025, Sandoz announced that TYRUKO® (natalizumab-sztn) is available to patients in the US. Developed by…
On Oct. 27, 2025, researchers at University of California San Diego School of Medicine (UC San Diego) have…
On Jun. 30, 2025, the Broad Institute announced that spatial mapping reveals genes contributing to fibrosis, or scarring,…
On Oct. 31, 2023, the U.S. Food and Drug Administration (FDA) announced it had approved Amgen’s Wezlana (ustekinumab-auub)…
On May 18, 2023, the U.S. Food and Drug Administration (FDA) approved approved Rinvoq (upadacitinib) for adults with moderately…
On Nov. 12, 2015, the University of Nebraska Medical Center and Nebraska Medicine announced receipt of a major…
In 1979, Centocor was founded – one of the nation’s first biotechnology companies best known for developing Remicade…